Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 20273 | 405 | 23.6 | 61% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NIMESULIDE | Author keyword | 24 | 22% | 24% | 98 |
| 2 | CAS 51803 78 2 | Author keyword | 20 | 100% | 2% | 9 |
| 3 | AULINR | Author keyword | 14 | 100% | 2% | 7 |
| 4 | MESULIDR | Author keyword | 8 | 100% | 1% | 5 |
| 5 | NIMEDR | Author keyword | 8 | 100% | 1% | 5 |
| 6 | CLIN PHARMACOKINET BIOAVAI IL | Address | 6 | 100% | 1% | 4 |
| 7 | NISULIDR | Author keyword | 6 | 100% | 1% | 4 |
| 8 | PHARMACOKINET BIOANALYT RADIOCHEM | Address | 4 | 75% | 1% | 3 |
| 9 | VALDECOXIB | Author keyword | 4 | 17% | 5% | 20 |
| 10 | ETORICOXIB | Author keyword | 3 | 13% | 6% | 24 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NIMESULIDE | 24 | 22% | 24% | 98 | Search NIMESULIDE | Search NIMESULIDE |
| 2 | CAS 51803 78 2 | 20 | 100% | 2% | 9 | Search CAS+51803+78+2 | Search CAS+51803+78+2 |
| 3 | AULINR | 14 | 100% | 2% | 7 | Search AULINR | Search AULINR |
| 4 | MESULIDR | 8 | 100% | 1% | 5 | Search MESULIDR | Search MESULIDR |
| 5 | NIMEDR | 8 | 100% | 1% | 5 | Search NIMEDR | Search NIMEDR |
| 6 | NISULIDR | 6 | 100% | 1% | 4 | Search NISULIDR | Search NISULIDR |
| 7 | VALDECOXIB | 4 | 17% | 5% | 20 | Search VALDECOXIB | Search VALDECOXIB |
| 8 | ETORICOXIB | 3 | 13% | 6% | 24 | Search ETORICOXIB | Search ETORICOXIB |
| 9 | NIMESULIDE BETA CYCLODEXTRIN | 3 | 100% | 1% | 3 | Search NIMESULIDE+BETA+CYCLODEXTRIN | Search NIMESULIDE+BETA+CYCLODEXTRIN |
| 10 | CYCLOOXYGENASE II INHIBITOR | 1 | 50% | 0% | 2 | Search CYCLOOXYGENASE+II+INHIBITOR | Search CYCLOOXYGENASE+II+INHIBITOR |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HYDROXYNIMESULIDE | 20 | 100% | 2% | 9 |
| 2 | ANTIINFLAMMATORY DRUG NIMESULIDE | 4 | 75% | 1% | 3 |
| 3 | MK 0663 | 4 | 75% | 1% | 3 |
| 4 | CYCLOOXYGENASE II INHIBITOR | 3 | 100% | 1% | 3 |
| 5 | ULTRAVIOLET ABSORBENCY DETECTION | 2 | 16% | 2% | 10 |
| 6 | METALLOPROTEASE SYNTHESIS | 1 | 38% | 1% | 3 |
| 7 | VAIDECOXIB | 1 | 100% | 0% | 2 |
| 8 | POSTCOLUMN PHOTOCHEMICAL DERIVATIZATION | 1 | 24% | 1% | 4 |
| 9 | DIHYDRODIGOXIN | 1 | 50% | 0% | 1 |
| 10 | POSTCOLUMN ULTRAVIOLET IRRADIATION | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Clinical pharmacokinetics of nimesulide | 1998 | 82 | 32 | 66% |
| Review of the applications of different analytical techniques for coxibs research | 2011 | 2 | 114 | 85% |
| An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices | 2005 | 38 | 112 | 56% |
| NIMESULIDE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY | 1994 | 155 | 38 | 74% |
| Chromatographic techniques in analysis of cyclooxygenase-2 inhibitors in drugs and biological samples | 2012 | 1 | 69 | 72% |
| Nimesulide: A selective cyclooxygenase 2 inhibitor antiinflammatory drug | 1996 | 42 | 64 | 63% |
| NIMESULIDE - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN INFLAMMATION AND PAIN STATES | 1988 | 62 | 20 | 100% |
| Safety profile of nimesulide: Ten years of clinical experience | 1997 | 13 | 14 | 86% |
| Clinical Pharmacokinetic and Pharmacodynamic Profile of Etoricoxib | 2008 | 8 | 75 | 25% |
| Nimesulide | 2007 | 0 | 28 | 64% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLIN PHARMACOKINET BIOAVAI IL | 6 | 100% | 1.0% | 4 |
| 2 | PHARMACOKINET BIOANALYT RADIOCHEM | 4 | 75% | 0.7% | 3 |
| 3 | PHYS METHODOL | 3 | 60% | 0.7% | 3 |
| 4 | COX 2 TECHNOL | 1 | 100% | 0.5% | 2 |
| 5 | BIOCITECH | 1 | 50% | 0.2% | 1 |
| 6 | EXPT CLIN PHARMAKOL TOXIKOL | 1 | 50% | 0.2% | 1 |
| 7 | HPLCUV GRP | 1 | 50% | 0.2% | 1 |
| 8 | IST DISCIPLINE OTORINOLARINGOIATRICHE | 1 | 50% | 0.2% | 1 |
| 9 | KYUNG HEE DRUG ANAL | 1 | 50% | 0.2% | 1 |
| 10 | MED RECORDS HLTH INFORMAT MANAGEMENT | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000164030 | PROSTAGLANDIN H SYNTHASE//IMRECOXIB//AB HANCOCK JR MEM CANC |
| 2 | 0.0000101961 | DIACEREIN//DIACERHEIN//DIACETYLRHEIN |
| 3 | 0.0000100594 | MELOXICAM//PIROXICAM//TENOXICAM |
| 4 | 0.0000097682 | NSAIDS//COXIBS//ROFECOXIB |
| 5 | 0.0000089931 | ACECLOFENAC//MEFENAMIC ACID//CAS 15307 86 5 |
| 6 | 0.0000073697 | ETODOLAC//CAS 41340 25 4//DEXTRAN CARRIER |
| 7 | 0.0000069662 | DOXAZOSIN MESYLATE//SELECTIVE ALPHA1 BLOCKERS//ALFUZOSIN HYDROCHLORIDE |
| 8 | 0.0000067634 | OXIDANT ANTIOXIDANT PARAMETERS//RUMEX JAPONICUS//METYROSINE |
| 9 | 0.0000063463 | OPERATIONAL QUALIFICATION//PERFORMANCE QUALIFICATION//DESIGN QUALIFICATION |
| 10 | 0.0000059035 | PRIMARY DYSMENORRHEA//DYSMENORRHEA//MENSTRUAL PAIN |